| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.00073 | 1 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.00068 | 1 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.00098 | 1 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.00061 | 1 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.00063 | 1 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.00057 | 1 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.00075 | 1 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.00038 | 1 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.00036 | 1 |